Telephone Administered Psychotherapy for the Treatment of Depression for Veterans in Rural Areas
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00012974|
Recruitment Status : Completed
First Posted : March 16, 2001
Last Update Posted : April 7, 2015
|Condition or disease||Intervention/treatment||Phase|
|Heart Failure Beta-blocker Treatment||Behavioral: GTelephone-administered Cognitive-Behavioral Therapy (T-CBT) Procedure: Provider education, computer reminders, nurse case management||Phase 1 Phase 2|
More that 20% of patients in primary care have depressive disorders. While primary care is the principal venue for treatment for depression, fewer than 25% of depressed patients receive adequate treatment for their depression. These outcomes can be worse when there are barriers to treatment such as living in a rural area. Several studies have found that given a choice, about two-thirds of depressed primary care patients prefer psychotherapy or counseling over antidepressant medication.
This is a controlled, randomized trial in which subjects meeting criteria for major depressive disorder (MDD) from primary care settings in VISN 21 including CBOCs will be randomly assigned to one of two conditions: 1) a 16-session manualized telephone administered cognitive behavioral therapy (T-CBT) delivered over 24 weeks or 2) a treatment-as-usual (TAU) condition. Telephone-administered cognitive behavioral therapy (T-CBT) is an intervention aimed at improving coping skills and social functioning. It is divided into two phases: 1) an initial treatment phase consisting of 12 weekly sessions aimed at reducing symptoms of depression, and 2) a booster phase in which 4 sessions are provided at increasingly greater intervals to target maintenance of treatment gains. T-CBT, administered by doctoral level psychologists, will be compared to a treatment-as-usual (TAU) condition that controls for the natural course of depression during the course of treatment.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||60 participants|
|Intervention Model:||Factorial Assignment|
|Masking:||None (Open Label)|
|Official Title:||Innovative Strategies for Implementing New CHF Guideline Recommendations|
|Study Start Date :||November 2005|
|Actual Study Completion Date :||May 2007|
Behavioral: GTelephone-administered Cognitive-Behavioral Therapy (T-CBT)
Procedure: Provider education, computer reminders, nurse case management
- Reduction in severity of depression; scores on depression rating scales at baseline, 12 weeks and 24 weeks
- Maintenance of treatment gains at 6 month follow-up (week 48).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00012974
|United States, California|
|VA Northern California Health Care System, Mather, CA|
|Sacramento, California, United States, 95655|
|San Francisco VA Medical Center, San Francisco, CA|
|San Francisco, California, United States, 94121|
|Principal Investigator:||Barry M Massie, MD||San Francisco VA Medical Center, San Francisco, CA|